Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology
- PMID: 22542950
- DOI: 10.1016/j.ctrv.2012.04.002
Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology
Abstract
Purpose: Dysphagia is a debilitating complication in head and neck cancer patients (HNCPs) that may cause a high mortality rate for aspiration pneumonia. The aims of this paper were to summarize the normal swallowing mechanism focusing on its anatomo-physiology, to review the relevant literature in order to identify the main causes of dysphagia in HNCPs and to develop recommendations to be adopted for radiation oncology patients. The chemotherapy and surgery considerations on this topic were reported in recommendations only when they were supposed to increase the adverse effects of radiotherapy on dysphagia.
Materials and methods: The review of literature was focused on studies reporting dysphagia as a pre-treatment evaluation and as cancer and cancer therapy related side-effects, respectively. Relevant literature through the primary literature search and by articles identified in references was considered. The members of the group discussed the results and elaborated recommendations according to the Oxford CRBM levels of evidence and recommendations. The recommendations were revised by external Radiation Oncology, Ear Nose and Throat (ENT), Medical Oncology and Speech Language Pathology (SLP) experts.
Results: Recommendations on pre-treatment assessment and on patients submitted to radiotherapy were given. The effects of concurrent therapies (i.e. surgery or chemotherapy) were taken into account.
Conclusions: In HNCPs treatment, disease control has to be considered in tandem with functional impact on swallowing function. SLPs should be included in a multidisciplinary approach to head and neck cancer.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.Clin Oncol (R Coll Radiol). 2014 Nov;26(11):697-703. doi: 10.1016/j.clon.2014.08.009. Epub 2014 Sep 16. Clin Oncol (R Coll Radiol). 2014. PMID: 25239671 Clinical Trial.
-
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.Crit Rev Oncol Hematol. 2015 Nov;96(2):372-84. doi: 10.1016/j.critrevonc.2015.06.005. Epub 2015 Jun 19. Crit Rev Oncol Hematol. 2015. PMID: 26141260 Review.
-
Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer.Eur J Radiol. 2006 Sep;59(3):453-9. doi: 10.1016/j.ejrad.2006.03.019. Epub 2006 May 9. Eur J Radiol. 2006. PMID: 16687229
-
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.Arch Otolaryngol Head Neck Surg. 2008 Oct;134(10):1060-5. doi: 10.1001/archotol.134.10.1060. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18936351
-
Prophylactic swallowing exercises for patients receiving radiotherapy for head and neck cancer.Curr Opin Otolaryngol Head Neck Surg. 2011 Jun;19(3):144-9. doi: 10.1097/MOO.0b013e3283457616. Curr Opin Otolaryngol Head Neck Surg. 2011. PMID: 21430531 Review.
Cited by
-
Strategies for non-resectable head and neck cancer.Curr Treat Options Oncol. 2013 Dec;14(4):492-504. doi: 10.1007/s11864-013-0260-6. Curr Treat Options Oncol. 2013. PMID: 24065559
-
Simultaneous Integrated Boost Radiotherapy in Unresectable Stage IV (M0) Head and Neck Squamous Cell Cancer Patients: Daily Clinical Practice.Rep Pract Oncol Radiother. 2020 May-Jun;25(3):399-404. doi: 10.1016/j.rpor.2020.04.006. Epub 2020 Apr 13. Rep Pract Oncol Radiother. 2020. PMID: 32368191 Free PMC article.
-
Validity and Reliability of an Arabic Version of MD Anderson Dysphagia Inventory (MDADI).Dysphagia. 2022 Aug;37(4):946-953. doi: 10.1007/s00455-021-10356-7. Epub 2021 Aug 24. Dysphagia. 2022. PMID: 34427776
-
Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.Support Care Cancer. 2016 Jun;24(6):2793-805. doi: 10.1007/s00520-016-3153-y. Epub 2016 Mar 17. Support Care Cancer. 2016. PMID: 26984249 Free PMC article. Review.
-
[Late toxicity following primary conservative treatment : Dysphagia and xerostomia].HNO. 2021 Apr;69(4):263-277. doi: 10.1007/s00106-020-00961-7. Epub 2020 Nov 12. HNO. 2021. PMID: 33180145 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous